Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
5,550 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01130753 | Efficacy of Erlotinib in Neoadjuvant Setting in Patients With Stage IIIA, N2-positive Non-Small Cell Lung Cancer | completed | Phase 2 | 43 | Samsung Medical CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT01863355 | Comparison of Analgesic Efficacy and Occurrence of Emesis Among Different Background Infusion and Bolus Administration Regimens of Fentanyl Based Intravenous Patient-controlled Analgesia in Patients After Laparoscopic Assisted Gastrectomy - a Randomized Blind Study - | unknown | N/A | 225 | Yonsei UniversityOTHER | 1 |
| May 27, 2013 |
| clinicaltrials |
| NCT01455584 | Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid Tumors | completed | Phase 1 | 20 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | May 23, 2013 | clinicaltrials |
| NCT01861197 | Phase II Study of Dovitinib for FGFR1 Amplified Squamous Non-small Cell Lung Cancer | unknown | Phase 2 | 27 | Samsung Medical CenterOTHER | 1 | May 23, 2013 | clinicaltrials |
| NCT01215513 | Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients | completed | Phase 3 | 127 | Ferring PharmaceuticalsINDUSTRY | 1 | May 22, 2013 | clinicaltrials |
| NCT01856452 | Comparison Study of Sentinel Lymph Node Biopsy by Multimodal Method in Breast Cancer | completed | Phase 2 | 86 | National Cancer Center, KoreaOTHER_GOV | 1 | May 17, 2013 | clinicaltrials |
| NCT00062257 | Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer | completed | Phase 2 | — | Cancer Therapeutics Research GroupOTHER | 4 | May 15, 2013 | clinicaltrials |
| NCT00077415 | 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 31 | Cancer Therapeutics Research GroupOTHER | 4 | May 15, 2013 | clinicaltrials |
| NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | completed | Phase 2 | 159 | AbbVie (prior sponsor, Abbott)INDUSTRY | 14 | May 15, 2013 | clinicaltrials |
| NCT01851941 | A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer | completed | Phase 2 | 52 | Seoul National University HospitalOTHER | 1 | May 13, 2013 | clinicaltrials |
| NCT01852487 | Effect of Pumpkin Seed Oil on Hair Growth in Men With Androgenetic Alopecia | completed | N/A | 80 | Dream PlusINDUSTRY | 1 | May 13, 2013 | clinicaltrials |
| NCT01837511 | Analysis of the Incidence of Expression of Tumor Antigens in Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer(NSCLC) in Asiatic Patients | completed | — | 377 | GlaxoSmithKlineINDUSTRY | 2 | Apr 23, 2013 | clinicaltrials |
| NCT01706393 | Effects of Probiotics Supplementation on Intestinal Microbiome in Malignancy Pts(Get Pelvic/Abdominal Rtx)(RTxIMprobio) | unknown | N/A | 26 | Seoul National University HospitalOTHER | 1 | Apr 19, 2013 | clinicaltrials |
| NCT00818090 | Paclitaxel and Cisplatin for Thymic Neoplasm | terminated | Phase 2 | 39 | Korean Cancer Study GroupOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01830153 | RAD001 in Advanced Sarcoma | completed | Phase 2 | 41 | Asan Medical CenterOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00828594 | Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma | terminated | Phase 1 | 130 | Novartis PharmaceuticalsINDUSTRY | 5 | Apr 11, 2013 | clinicaltrials |
| NCT01238055 | Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer | completed | Phase 2 | 116 | Samsung Medical CenterOTHER | 1 | Apr 9, 2013 | clinicaltrials |
| NCT00986843 | Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102) | completed | Phase 1 | 14 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | Apr 5, 2013 | clinicaltrials |
| NCT01824004 | Postoperative Chemoradiotherapy With S-1 in Gastric Cancer | completed | Phase 2 | 46 | Chonnam National University HospitalOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT01538498 | Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer | completed | — | 134 | National Cancer Center, KoreaOTHER_GOV | 1 | Mar 28, 2013 | clinicaltrials |
| NCT00521430 | Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease | completed | N/A | 30 | Asan Medical CenterOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00569283 | Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant | completed | Phase 1 | 18 | Asan Medical CenterOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00618501 | Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | completed | Phase 2 | 50 | Asan Medical CenterOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00627666 | Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer | completed | Phase 2 | 52 | Asan Medical CenterOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT01463059 | Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy | completed | Phase 2 | 119 | UCB Japan Co. Ltd.INDUSTRY | 3 | Mar 25, 2013 | clinicaltrials |
| NCT00494091 | Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma | completed | Phase 2 | 82 | PfizerINDUSTRY | 3 | Mar 21, 2013 | clinicaltrials |
| NCT01294722 | A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea | completed | — | 1,700 | Janssen Korea, Ltd., KoreaINDUSTRY | 1 | Mar 19, 2013 | clinicaltrials |
| NCT01813344 | Hyper-CVAD Treatment in Lymphoblastic Lymphoma(LBL-CISL-1) | unknown | — | 50 | Ajou University School of MedicineOTHER | 1 | Mar 19, 2013 | clinicaltrials |
| NCT00379574 | Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL | completed | Phase 1 / Phase 2 | 49 | Asan Medical CenterOTHER | 1 | Mar 15, 2013 | clinicaltrials |
| NCT01786538 | Second-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus Fluoropyrimidines | withdrawn | Phase 3 | 0 | Asan Medical CenterOTHER | 1 | Mar 13, 2013 | clinicaltrials |
| NCT00676650 | Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy(SUN 1120) | terminated | Phase 3 | 873 | PfizerINDUSTRY | 22 | Mar 8, 2013 | clinicaltrials |
| NCT00824746 | Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)(ReGaiN) | completed | Phase 2 | 23 | Chonnam National University HospitalOTHER | 1 | Feb 26, 2013 | clinicaltrials |
| NCT01659619 | Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric Stasis | completed | Phase 2 | 114 | The Catholic University of KoreaOTHER | 1 | Feb 21, 2013 | clinicaltrials |
| NCT00411229 | Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer(CLASSIC) | completed | Phase 3 | 1,035 | SanofiINDUSTRY | 3 | Feb 20, 2013 | clinicaltrials |
| NCT00823524 | Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer | completed | Phase 1 / Phase 2 | 47 | Asan Medical CenterOTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT01005628 | Bortezomib (Velcade) - Regulatory Post Marketing Surveillance (PMS) | completed | — | 1,121 | Janssen Korea, Ltd., KoreaINDUSTRY | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00550173 | A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer | completed | Phase 2 | 247 | Eli Lilly and CompanyINDUSTRY | 7 | Feb 13, 2013 | clinicaltrials |
| NCT01660568 | Gemcitabine in NK/T Cell Lymphoma | completed | — | 20 | Samsung Medical CenterOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT01071915 | Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer | completed | Phase 3 | 157 | Ferring PharmaceuticalsINDUSTRY | 1 | Feb 12, 2013 | clinicaltrials |
| NCT01789060 | p-AKT Expression on Clinical Outcomes in Malignant Lymphoma | completed | — | 262 | Samsung Medical CenterOTHER | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00558103 | Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer | completed | Phase 2 | 163 | GlaxoSmithKlineINDUSTRY | 28 | Feb 4, 2013 | clinicaltrials |
| NCT01778192 | A Randomized Prospective Trial Comparing Polyethylene Glycol and Sodium Picosulphate With Magnesium Citrate | completed | Phase 3 | 200 | Korea University Anam HospitalOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT01629524 | Influence of Tumor Associated Immunity on the Number of Lymph Node Retrieved After Colorectal Cancer Surgery (Preliminary Study) | completed | — | 25 | Yonsei UniversityOTHER | 1 | Jan 30, 2013 | clinicaltrials |
| NCT01196234 | Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer(PRIDE) | completed | Phase 2 | 84 | Asan Medical CenterOTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT01510990 | First Line Gefitinib by FDG-PET Metabolic Response | unknown | Phase 2 | 60 | Asan Medical CenterOTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT01266811 | A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma | withdrawn | Phase 3 | 0 | Centocor, Inc.INDUSTRY | 14 | Jan 28, 2013 | clinicaltrials |
| NCT01776684 | Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis | unknown | N/A | 200 | Samsung Medical CenterOTHER | 1 | Jan 28, 2013 | clinicaltrials |
| NCT00378066 | Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer | completed | Phase 2 | 49 | Asan Medical CenterOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00694382 | Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy(SAVE-ONCO) | completed | Phase 3 | 3,212 | SanofiINDUSTRY | 49 | Jan 23, 2013 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials